The SCN5A gene encodes the pore-forming -subunit of the cardiac fast sodium channel (I Na channel). Carriers of the 1795insD mutation in SCN5A show sinus bradycardia, with a mean heart rate of 70 bpm in mutation carriers vs. 77 bpm in non-carriers from the same family (lowest heart rate 41 vs. 47 bpm).
Introduction
The 'fast sodium current' (I Na ), which flows through Na V 1.5 sodium channels, is a key player in the electrical activity of the human heart [1] . The cardiac-specific Na V 1.5 protein, encoded by the SCN5A gene, is the poreforming -subunit of the channel. Of note, a functional I Na channel is built with a single Na V 1.5 protein, in contrast with, for example, a functional 'pacemaker current' or 'funny current' (I f ) channel, which is a tetramer of four proteins from the HCN family, in particular HCN4 [2, 3] .
The large and fast influx of sodium ions through the Na V 1.5 channels is not only responsible for the fast upstroke of individual atrial and ventricular cardiomyocytes, but also for the fast impulse propagation in the atrial and ventricular tissue. Thus, I Na is an important determinant of the PQ interval, or PR interval, and the QRS duration on the body surface ECG. I Na has also been observed in human sinoatrial node cells [4] . Accordingly, it was included in the comprehensive computational model of a single human sinoatrial node (SAN) cell that was recently developed by Fabbri et al. [5] .
Mutations in genes encoding ion channel-related proteins may result in inherited arrhythmia disorders, in particular the long QT syndrome (LQTS), which shows an estimated prevalence of 1:2,000 [6] and is the most commonly encountered inherited arrhythmia disorder in clinical practice ( 35 [7] ). LQTS type 3 (LQT3) is caused by gain-of-function mutations in the SCN5A gene. Slowed or incomplete inactivation of the Na V 1.5 channel results in an additional inward current, known as late or persistent I Na , during the course of the ventricular action potential and thereby in prolongation of the long QT interval on the ECG. The estimated prevalence of LQT3 among LQTS patients is 10 [8, 9] .
An intriguing and widely studied mutation among the mutations in SCN5A associated with LQT3 is 1795insD, which is not only characterized by QT prolongation, but also by atrial and ventricular conduction delays, and nocturnal sudden cardiac death. Carriers of this mutation may not only present with LQT3, but also with Brugada syndrome and with sinus bradycardia [10] . In line with the conduction delays and the Brugada phenotype, lossof-function mutational effects were observed in patch clamp experiments on wild-type and mutant Na + channels expressed in Xenopus oocytes. The steady-state activation curve was shifted by +8.1 mV, whereas the steady-state inactivation curve was shifted by 7.3 mV. Also, the fully-activated I Na was reduced by 78 [10] . The QT prolonging effects could be explained by the persistent I Na of 1.5 (percent of peak I Na ) that was observed in patch clamp experiments on wild-type and mutant Na + channels expressed in HEK-293 cells [11] .
Holter recording in 1795insD patients revealed sinus bradycardia with an 11 decrease in minimum, average, and maximum heart rate [12] , as detailed in Table 1 , which also shows the bradycardic effect of some typical HCN4 mutations [13] [14] [15] for comparison.
We studied the mechanisms of the 1795insD mutationinduced bradycardia at the cellular level with the use of the comprehensive computational model of a single human SAN cell of Fabbri et al. [5] .
Methods
Effects of the heterozygous 1795insD mutation in SCN5A were implemented in the CellML code [16] of the Fabbri et al. human SAN cell model [5] by scaling the fully-activated conductance of I Na , shifting the voltage dependence of I Na activation and inactivation, and introducing a percentage of non-inactivating I Na channels, based on the data from literature described in the Introduction. These modifications were applied to half of the intrinsic I Na , thus representing the heterozygous nature of the mutation.
The default Fabbri et al. model [5] has a beating rate of 74 bpm. This rate was lowered to 49 bpm (vagal tone) through the simulated administration of 20 nM acetylcholine (ACh). A beating rate of 140 bpm ( -adrenergic tone) was obtained through the simulated administration of isoprenaline (Iso), tuning the parameters affected by Iso to arrive at this beating rate.
The CellML code was edited and run in the Cellular Open Resource (COR) environment [17] , version 0.9.31.1409. All simulations were run for a sufficiently long time to reach steady-state behaviour.
Results
We started our simulations with the default SAN cell model (normal autonomic tone). The gain-of-function effect of the 1795insD mutation, i.e., the 1.5 persistent sodium current, shortens the cycle length of the model cell from 813 to 683 ms through a moderate increase in action potential duration ( Fig. 1A) and a more substantial increase in diastolic depolarization rate (Fig. 1A, red and dashed grey traces). The latter is caused by an increase in the net inward current during diastolic depolarization as a result of the increased I Na (Fig. 1, B and C) .
The gain-of-function effect of the persistent current is completely counteracted by the loss-of-function effect of the 78 decrease in the fully-activated I Na conductance (Fig. 1, green traces) . With the additional loss-of-function effect of the shifts in voltage dependence of I Na activation and inactivation, the net effect of the 1795insD mutation is an inhibition of I Na that results in an increase in cycle length from 813 to 867 ms (Fig. 1, blue traces) .
As illustrated in Fig. 2 , the effects of the 1795insD mutation are highly similar in the presence of 20 nM ACh (vagal tone). Similar mutation effects (data not shown) were observed at high beating rate through the simulated administration of isoprenaline ( -adrenergic tone).
The mutation effects on beating rate observed in our computer simulations are summarized in Fig. 3 , together with the clinical observations on the heart rate of heterozygous 1795insD mutation carriers by Van den Berg et al. [12] . The simulation results match the clinical data, but the decrease in beating rate of 8 is somewhat smaller than the clinically observed decrease in heart rate of 11 . In our single cell simulations, there is no hyperpolarizing effect on the SAN cell of the surrounding atrial tissue. Such hyperpolarizing effect may increase the availability of sodium channels and thus the effect of the (mutated) sodium current on beating rate.
Conclusion
We conclude that the experimentally identified effects of the 1795insD mutation on I Na can explain the clinically observed sinus bradycardia. Together, the loss-offunction effects of the shifts in the voltage dependence of I Na activation and inactivation and the decrease in fullyactivated conductance are stronger than the gain-offunction effect of the persistent current, resulting in an overall increase in cycle length through a decrease in net inward current during the final phase of diastolic depolarization. Furthermore, we conclude that the Fabbri et al. model may prove a useful tool in understanding cardiac pacemaker activity in human. 
